25 Recruiting Advanced Melanoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Advanced Melanoma
Related Conditions
Top Recruiting Advanced Melanoma Studies
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
📍 Thomas Hospital — Fairhope, Alabama
View Study & Checklist ➔Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma
📍 Scottsdale Healthcare Hospitals DBA HonorHealth — Scottsdale, Arizona
View Study & Checklist ➔A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
📍 Univ of Pittsburgh Medical Center Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔Naltrexone and Propranolol Combined With Immunotherapy
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
View Study & Checklist ➔Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
📍 University of Arizona — Tucson, Arizona
View Study & Checklist ➔A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔